Pfizer is expected to get full approval for its COVID-19 vaccine by Labor Day, according to The New York Times.
The Food and Drug Administration has not verified the timeline.
Category: Healthcare Finance News
Pfizer is looking for full approval of COVID-19 vaccine by Labor Day
3M partners with Waystar on AI revenue capture
3M is partnering with Waystar on AI automated revenue capture for the over 6,000 health systems and hospitals nationwide that are clients of its Health Information Systems division.
Acute care hospitals get a 2.5% pay increase in final rule
Acute care hospitals get a 2.5% pay rate increase for 2022 in the Centers for Medicare and Medicaid Services Hospital Inpatient Prospective Payment System final rule.
Kaiser sues Merck alleging ‘pay-for-delay’ anticompetitive agreement
Merck reaped billions while Kaiser and its members paid higher prices for two popular drugs to lower cholesterol, the lawsuit says.
AI, quantum computing and other technologies poised to transform healthcare
The COVID-19 pandemic has created numerous challenges in healthcare, but challenges can sometimes breed innovation. Technological innovation in particular is poised to change the way care is delivered, driving efficiency in the process. Efficiency will…
Healthcare will expand and deal with the fallout of COVID-19 for decades, says Fitch
The U.S. may have entered into a new phase of the COVID-19 pandemic, but the public health crisis is far from over and the nation’s hospitals and health systems will likely be dealing with its after effects for decades, according to new findings from F…
Vaccinated individuals are getting infected with the Delta variant, CDC data shows
The outbreak of coronavirus infections, including COVID-19 vaccine breakthrough infections, is associated with large public gatherings, including one in Barnstable County Massachuestts, according to the Centers for Disease Control and Prevention in its…
Drugs without a proven clinical benefit languish for years on the FDA’s accelerated pathway
Since the U.S. Food and Drug Administration established its accelerated approval pathway for drugs in 1992, 112 of the 253 drugs authorized have not been confirmed as clinically effective, an investigation by The BMJ has found.
Medicare Part D average premiums to increase nearly 5% in 2022, CMS says
The Centers for Medicare and Medicaid Services has released its projections for average basic monthly premiums for standard Medicare Part D coverage in 2022, which the agency expects will be about $33 — a 4.9% increase from the $31.47 average premium …
Skilled nursing, hospice and rehab facilities see payment increases in final rule
CMS has adopted a vaccination measure to assess whether skilled nursing facilities are taking steps to control the spread of COVID-19.
